Anticoagulation is not associated with an increased risk of variceal bleeding under systemic therapy for advanced HCC-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Anticoagulation is not associated with an increased risk of variceal bleeding under systemic therapy for advanced HCC

Published:2024-08 Issue:8 Volume:6 Page:101120
ISSN:2589-5559
Container-title:JHEP Reports
language:en
Short-container-title:JHEP Reports

Author:

Allaire Manon^ORCID,Sultanik Philippe,Thabut Dominique

Publisher

Elsevier BV

Reference7 articles.

1. Atezolizumab/bevacizumab or lenvatinib in hepatocellular carcinoma: multi-center real world study with focus on bleeding and thromboembolic events;Ben Khaled;JHEP Rep,2024

2. Portal hypertension is associated with poorer outcome and clinical liver decompensation in patients with HCC treated with Atezolizumab-Bevacizumab;Sultanik;Dig Liver Dis,2024

3. Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma;Finn;N Engl J Med,2020

4. Baveno VI and VII criteria are not suitable for screening for large varices or clinically significant portal hypertension in patients with hepatocellular carcinoma;Allaire;Aliment Pharmacol Ther,2023

5. Singal AG, Llovet JM, Yarchoan M, et al. AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma. Hepatology. https://doi.org/10.1097/HEP.0000000000000466.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Response to: “Anticoagulation is not associated with an increased risk of variceal bleeding under systemic therapy for advanced HCC”;JHEP Reports;2024-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3